FCNTX
Price
$19.61
Change
-$0.42 (-2.10%)
Updated
Sep 6 closing price
GFACX
Price
$61.91
Change
-$1.33 (-2.10%)
Updated
Sep 6 closing price
Ad is loading...

FCNTX vs GFACX

Header iconFCNTX vs GFACX Comparison
Open Charts FCNTX vs GFACXBanner chart's image
Fidelity Contrafund
Price$19.61
Change-$0.42 (-2.10%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$61.91
Change-$1.33 (-2.10%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FCNTX vs GFACX Comparison Chart
Loading...
VS
FCNTX vs. GFACX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCNTX is a Buy and GFACX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 270B vs. FCNTX (146B). FCNTX pays higher dividends than GFACX: FCNTX (0.42) vs GFACX (0.00). FCNTX was incepted earlier than GFACX: FCNTX (57 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. FCNTX (16.00). FCNTX has a lower initial minimum investment than GFACX: FCNTX (0) vs GFACX (250). FCNTX annual gain was more profitable for investors over the last year : 31.15 vs. GFACX (16.44). FCNTX return over 5 years is better than : 53.61 vs. GFACX (38.56).
FCNTXGFACXFCNTX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence57 years24 years-
Gain YTD24.51514.982164%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets146B270B54%
Annual Yield % from dividends0.420.00-
Returns for 1 year31.1516.44189%
Returns for 3 years0.67-11.08-6%
Returns for 5 years53.6138.56139%
Returns for 10 years97.1142.46229%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KW11.040.03
+0.27%
Kennedy-Wilson Holdings
CTVA55.11-0.39
-0.70%
Corteva
FIVN29.58-0.24
-0.80%
Five9
VEV0.14N/A
-1.68%
Vicinity Motor Corp
ADAP1.11-0.05
-4.31%
Adaptimmune Therapeutics plc